𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma

✍ Scribed by Masakazu Kohda; Hidetoshi Hoshiya; Motonobu Katoh; Isao Tanaka; Ryo Masuda; Tamiko Takemura; Mutsunori Fujiwara; Mitsuo Oshimura


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
262 KB
Volume
31
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Genomic imprinting is a parental origin-specific chromosomal modification that causes differential expression of maternal and paternal alleles of a gene. Accumulating evidence suggests that deregulation of imprinted genes, including loss of imprinting (LOI), plays a role in oncogenesis. In the present study, we investigated allelic expression of six imprinted genes in human lung adenocarcinomas as well as in matched normal lung tissue. Informative cases showing heterozygosity for the gene of interest were selected from 35 patients. LOI of the insulin-like growth factor 2 gene (IGF2) and mesoderm-specific transcript (MEST, also known as paternally expressed gene 1) was noted in 47% (seven of 15) and 85% (11 of 13) of informative cases, respectively. Monoallelic expression was maintained in all the matched normal tissues examined. LOI of IGF2 was seen more frequently in moderately to poorly differentiated adenocarcinomas. In contrast, H19, small nuclear ribonucleoprotein-associated polypeptide N gene (SNRPN), necdin gene (NDN), and long QT intronic transcript 1 (LIT1) exhibited consistent monoallelic expression in all the informative samples. These findings indicated that independent deregulation took place in imprinted genes and suggested that aberrant imprinting of IGF2 and MEST was involved in the development of lung adenocarcinoma.


πŸ“œ SIMILAR VOLUMES


Loss of imprinting of igf2 in renal-cell
✍ Hideaki Oda; Haruki Kume; Yasuhito Shimizu; Tohru Inoue; Takatoshi Ishikawa πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 75 KB πŸ‘ 2 views

Loss of imprinting (LOI) of the igf 2 and h19 genes has been found not only in embryonal tumors but also in common adult cancers. To determine any possible role of genomic imprinting in the development of renal-cell carcinomas (RCCs), we examined the imprinting status of igf 2 and h19 in a series of

Frequent loss of imprinting of the H19 a
✍ Kim, Hong Tae; Choi, Bo Hwa; Niikawa, Norio; Lee, Tae Sung; Chang, Sung Ik πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views

Several human imprinted genes have been identified and are implicated in genetic diseases and tumorigenesis. We studied alterations of two imprinted genes, the paternally imprinted H19 and maternally imprinted IGF2, in 15 ovarian tumors with various cell types. To know allele-specific expression of

Frequent EGFR mutations in brain metasta
✍ Shingo Matsumoto; Kenji Takahashi; Reika Iwakawa; Yoshihiro Matsuno; Yukihiro Na πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 249 KB

## Abstract Lung adenocarcinomas often metastasize to the brain, and the prognosis of patients with brain metastases is still very poor. The __epidermal growth factor receptor__ (__EGFR__) gene is mutated in a considerable fraction of primary lung adenocarcinomas, in particular those with drastic r

Prognostic value of loss of heterozygosi
✍ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

No evidence of microsatellite instabilit
✍ Lea PylkkΓ€nen; Antti Karjalainen; Sisko Anttila; Harri Vainio; Kirsti Husgafvel- πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 1 views

We examined microsatellite instability and loss of heterozygosity (LOH) in primary lung tumors from 93 cancer patients, using 16 microsatellite markers. The cases studied included 87 non-small-cell lung cancers (NSCLC) and six small-cell lung cancers (SCLC). All the patients except two were current